Viewing Study NCT00228358


Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2026-01-01 @ 2:23 PM
Study NCT ID: NCT00228358
Status: COMPLETED
Last Update Posted: 2014-11-11
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine
Sponsor:
Organization: